A Systematic Review of Research Gaps in the Evaluation and Management of Localized Renal Masses - 19/04/17
, Emmanuel Iyoha b, Phillip M. Pierorazio a, Stephen M. Sozio c, d, Michael H. Johnson a, Ritu Sharma b, Eric B. Bass b, Mohamad E. Allaf aAbstract |
The management of clinically localized renal masses suspicious for renal cell carcinoma varies, partially because of gaps in the evidence base. We conducted a systematic review to summarize research gaps for the evaluation of composite models for predicting malignancy; use of percutaneous renal sampling for diagnosis; and comparative effectiveness of surgery, thermal ablation, and active surveillance. A total of 147 studies, published in 150 articles, were identified. To promote improved patient care and health outcomes, we recommend incorporation of emerging biomarkers into validated composite models, standardization of biopsy protocols, standard reporting of clinical stage, and performance of prospective studies with objective selection criteria.
Le texte complet de cet article est disponible en PDF.Plan
| Financial Disclosure: Emmanuel Iyoha, Ritu Sharma, and Eric B. Bass are members of Evidence-Based Practice center, which was funded to conduct the systematic review by Contract No. HHSA290201200007I from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services. The remaining authors declare that they have no relevant financial interests. |
|
| The authors of this report are responsible for this work's content. Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. |
Vol 98
P. 14-20 - décembre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
